Saratoga Health & Biotechnology Portfolio Fund Class A (SHPAX)

Fund Assets	11.27M
Expense Ratio	3.00%
Min. Investment	$250
Turnover	22.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 9, 2025

Previous Close	24.26
YTD Return	13.12%
1-Year Return	31.50%
5-Year Return	36.87%
52-Week Low	19.02
52-Week High	24.26
Beta (5Y)	0.70
Holdings	27
Inception Date	Jul 15, 1999

About SHPAX

Saratoga Health & Biotechnology Portfolio Fund Class A is a mutual fund that primarily targets the health care and biotechnology sectors. The fund seeks long-term capital growth by investing at least 80% of its assets in equity securities of companies engaged in health care, pharmaceuticals, medical products, research, and biotechnology, both in the United States and internationally. Managed since 1999, it holds a diversified portfolio with approximately 32 holdings and notable concentrations in large-cap health care companies. Its top holdings include prominent industry names such as McKesson, Amgen, and Intuitive Surgical, reflecting a focus on market leaders within health innovation. The fund has an annual expense ratio of around 2.7% and requires a minimum initial investment of $250. With a strategy centered on growth in sectors driven by advances in medicine and technology, Saratoga Health & Biotechnology Portfolio Fund Class A plays a specialized role for investors seeking specific exposure to the evolving health and biotechnology industries.

• Fund Family: Saratoga
• Category: Health
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: NASDAQ
• Ticker Symbol: SHPAX
• Share Class: Class A
• Index: S&P 500 TR

Performance

SHPAX had a total return of 31.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.68%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SBHIX	Class I	2.60%
SHPCX	Health & Biotechnology Porfolio Class C	3.60%

Top 10 Holdings

51.24% of assets

Name	Symbol	Weight
Cardinal Health, Inc.	CAH	7.35%
Jazz Pharmaceuticals plc	JAZZ	5.96%
United Therapeutics Corporation	UTHR	5.67%
Amgen Inc.	AMGN	5.12%
Lantheus Holdings, Inc.	LNTH	4.90%
McKesson Corporation	MCK	4.71%
Exelixis, Inc.	EXEL	4.63%
Novartis AG ADR	NVSN.MX	4.44%
Cencora, Inc.	COR	4.30%
Johnson & Johnson	JNJ	4.17%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 9, 2025	$0.7788	Dec 10, 2025
Dec 10, 2024	$0.2534	Dec 11, 2024
Dec 8, 2023	$1.0202	Dec 11, 2023
Dec 9, 2022	$1.2749	Dec 12, 2022
Dec 10, 2021	$0.7883	Dec 13, 2021
Dec 11, 2020	$2.5794	Dec 11, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error